Future Financial Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,200
Closed -$54.1K 155
2025
Q3
$54.1K Hold
1,200
0.03% 244
2025
Q2
$55.5K Hold
1,200
0.04% 230
2025
Q1
$73.2K Sell
1,200
-50
-4% -$2.91K 0.05% 193
2024
Q4
$70.7K Sell
1,250
-125
-9% -$6.98K 0.05% 204
2024
Q3
$71.1K Buy
+1,375
New +$64.5K 0.05% 213
2024
Q2
Sell
-1,525
Closed -$82.7K 153
2024
Q1
$82.7K Buy
+1,525
New +$77.7K 0.06% 194
2023
Q1
Sell
-7,085
Closed -$510K 111
2022
Q4
$510K Sell
7,085
-120
-2% -$9.05K 0.58% 54
2022
Q3
$555K Sell
7,205
-91
-1% -$6.6K 0.64% 50
2022
Q2
$533K Hold
7,296
0.52% 63
2022
Q1
$533K Buy
7,296
+617
+9% +$41.4K 0.44% 63
2021
Q4
$413K Buy
+6,679
New +$392K 0.33% 72

Other funds holding BMY

Future Financial Wealth Management's BMY Position: Q4 2025 in Review

Future Financial Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 1,200 shares — an estimated $54.1K sold.

Future Financial Wealth Management first reported a position in BMY in Q4 2021 and held it in 11 quarters. The position peaked at $555K in Q3 2022. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Future Financial Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Future Financial Wealth Management sold 1,200 Bristol-Myers Squibb shares in Q4 2025, an estimated $54.1K.
  • Future Financial Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 11 quarters.
  • Future Financial Wealth Management's Bristol-Myers Squibb position peaked at $555K in Q3 2022.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Future Financial Wealth Management's 13F filing for Q4 2025, filed 21 Jan 2026.